ANESTHESIA OVERVIEW - PowerPoint PPT Presentation

1 / 96
About This Presentation
Title:

ANESTHESIA OVERVIEW

Description:

A a myelinated motor. A alpha myelinated touch-pressure. A beta myelinated touch-pressure ... Dorsal horn to thalamic. Third Neuron Pain. Thalamus to cortex ... – PowerPoint PPT presentation

Number of Views:308
Avg rating:3.0/5.0
Slides: 97
Provided by: classe5
Category:

less

Transcript and Presenter's Notes

Title: ANESTHESIA OVERVIEW


1

BASICANESTHESIA PRACTICE
2
ANESTHESIA DEFINITION
  • TRADITIONAL
  • LOSS OF SENSATION WITH OR WITHOUT LOSS OF
    CONSCIOUSNESS

3
MECHANISMS OF ACTION
  • Interaction at cellular receptor site
  • Action Intracellular
  • Cortical depression

4
PAIN
  • Pain is always subjective. Each individual
    learns the application of the word through
    experiences related in early life.

5
I.A.S.P.
  • International Association for Study of Pain

6
Pain
  • An unpleasant sensory and emotional experience
    associated with actual or potential tissue damage
    or injury, or described in terms of such damage
    or injury.

7
ETIOLGY OF PAIN
  • HEAT
  • COLD
  • CHEMICAL
  • MECHANICAL
  • TORSION STRETCH CUT PINCH PRICK
    COMPRESS CRUSH

8
TYPOLOGY OF PAIN
  • Acute
  • Chronic benign
  • Chronic cancer

9
Chronic Pain vs Acute Pain
  • Acute A Symptom of Injury or Disease
  • Chronic Benign Pain itself is the disease
  • Chronic Cancer Actual Tissue destruction

10
Acute Pain
  • A complex constellation of unpleasant sensory,
    perceptive and emotional experiences and certain
    associated autonomic psychological, emotional
    behavioral responses provoked by noxious
    stimulation.

11
CHRONIC PAIN
  • PAIN THAT PERSIST BEYOND
  • USUAL COURSE OF HEALING
  • (3 - 6 MONTHS)

12
Adverse Effects of Pain
  • Cardiovascular
  • Pulmonary
  • Gastrointestinal
  • Renal
  • Extremities
  • Endocrine
  • CNS
  • Immunologic

13
Adverse Effects of Pain
  • Cardiovascular Tachycardia, hypertension,
    increased SVR, increased cardiac work, increased
    myocardial O2 demand.
  • Pulmonary Hypoxia, hypercarbia, atelectasis,
    decreased cough, decreased vital capacity and
    function residual capacity, V/Q mismatch.
  • Gastrointestinal Nausea, vomiting, ileus,
    intolerance for oral intake.
  • Renal Oliguria, urinary retention.

14
Adverse Effects of Pain
  • Extremities Skeletal muscle spasm, limited
    mobility, thromboembolism.
  • Endocrine Excessive adrenergic activity, vagal
    inhibition, catabolic metabolism, increased O2
    consumption.
  • CNS Sedation, fatigue, anxiety, and fear cause
    central sympathetic stimulation.
  • Immunologic Inhibited cellular immunity,
    increased risk of infection, ?? impaired wound
    healing ??

15
FREE NERVE ENDINGS ARE PRESENT IN ESSENTIALLY ALL
BODY TISSUES IN VARYING AMOUNTS
16
IN RESPONSE TO A PAINFUL STIMULUS, SUBSTANCES ARE
EXCRETED.
17
ALGOGENIC(substances released by pain)
  • SEROTONIN POTASSIUM
  • HISTAMINE ACETLYCHOLINE
  • BRADYKININS LEUKOTRIENES
  • PROSTAGLANDINS SUBSTANCE P29
  • NOREPINEPHRINE

18
THE RECEPTORS IN THE FREE NERVE ENDINGS RESPOND
TO THE SUBSTANCES BY BECOMING CHARGED
ELECTROCHEMICALY
19
RECEPTORS THEN PROPAGATE AN ELECTROCHEMICAL
STIMULUS TO DIFFERING NERVE FIBERS
20
NOCICEPTION
  • This electrochemical event that occurs
    between the site of tissue damage or injury sets
    off a series of neural transmissions that
    eventually results in the perception of
    painCollectively this known as nociception

21
NERVE FIBERPAIN CLASSIFICATION
  • A FIBER..SHARP-STABBING-LOCAL
  • FIRST PAIN
  • B FIBER....PHYSIOLOGIAL REACTION
  • C FIBER....DULL-ACHE-BURN-THROB
  • NONLOCALIZED-RADIATE
  • SECOND PAIN

22
NERVE FIBER CLASSIFCATION
  • TYPE FUNCTION
  • A a myelinated motor
  • A alpha myelinated touch-pressure
  • A beta myelinated touch-pressure
  • A delta myelinated pain-temperature
  • A gamma myelinated proprioception

23
A Delta
  • 1 - 4 micrometers diameter
  • Myelinated, Rapid conduction
  • Sharp, localized
  • Heat, cold
  • First pain

24
NERVE FIBER CLASSIFCATION
  • TYPE FUNCTION
  • B myelinated preganglionic autonomic
  • C non-myelinated pain-temperature

25
C Fibers
  • Small
  • Slow Conduction
  • Unmyelinated
  • Postganglionic autonomic

26
C Fibers
  • Dull pain, burning, Aching throbbing
  • Nonlocalized - radiating - diffused
  • Temperature,Touch,Mechanical
  • Second pain

27
Gate Theory
  • Balance between A delta and C fibers to dorsal
    horn determines the intensity of the stimulus
    that is passed to higher brain center

28
Area of High Nociceptor Concentration
  • Mucosal membranes
  • Periosteum
  • Deep fascia
  • Ligaments
  • Joint capsules
  • Cornea
  • Subcutaneous tissue

29
Areas of Moderate Nociceptor Concentration
  • Skeletal muscle
  • Cardiac muscle
  • Smooth muscle

30
Areas of Minimal Nociceptor Concentration
  • Bone
  • Cartilage
  • Marrow

31
Physiologic Processes of Nociception
  • Detection
  • Transduction
  • Transmission
  • Modulation
  • Perception

32
Detection
  • First pain
  • Second pain

33
TRANSDUCTION
  • NOXIOUS STIMULI TRANSLATED INTO ELECTRICAL FIRING
    AT THE SENSORY NERVE ENDINGS

34
TRANSMISSION
  • PROPAGATION OF IMPULSE TRAVELS VIA NEURAL
    PATHWAYS.
  • SENSORY AFFERENT NEURONS PROJECT INTO THE
    SPINAL CORD
  • ASCENDING NEURONS RELAY TO BRAINSTEM AND THALAMUS
  • THALAMUS RELAYS TO CEREBRAL CORTEX

35
MODULATION
  • INTRINIC PAIN MODIFICATION
  • 1.DIFFERENT IN INDIVIDUALS
  • 2.DEPENDS ON.....
  • PAST EXPERIENCES
  • CULTURE
  • PSYCHIC

36
MODULATION-CONT
  • STIMULUS PRODUCED ANALGESIA
  • NEUROENDOCRINE ANALGESIA
  • CNS/PNS ANALGESIA
  • OPIOID ANALGESIA
  • SITUATION
  • PATHOLOGY
  • PHYSIOLOGY

37
Modulation Excitatory Substances
  • Peripheral
  • Prostaglandins, bradykinins, histamine, K,
    substance P, serotonin (5HT2)
  • Spinal
  • Glutamate, aspartate, amino acids, substance P,
    norepinephrine (alpha 1)

38
Modulation - Inhibitory
  • Supraspinal
  • Endorphins, enkephalins, dynorphins,
    norepinephrine (alpha 2), GABA, somatostatin
    (5HT1), neurotensin

39
First Neuron Pain
  • Peripheral afferent fibers to dorsal horn
  • Second Neuron Pain
  • Dorsal horn to thalamic
  • Third Neuron Pain
  • Thalamus to cortex

40
IDEAL ANESTHETIC
  • 1. SEDATION - HYPNOSIS
  • 2. AMNESIA
  • 3. ANALGESIA
  • 4. MUSCLE RELAXATION
  • 5. OBTUND REFLEXES
  • 6. PHYSIOLOGICAL STABILITY
  • 7. REVERSIBLE
  • 8. ANTIEMETIC

41
IDEAL COMPONENTS
  • Block SENSORY feeling
  • Immobilize MOTOR responses
  • Obtund REFLEXES
  • wipe out MEMORY
  • Control VC and CTZ
  • Not permanent
  • Cause sense of well-being

42
DELIVERY METHODS
  • 1. REGIONAL ( conduction)
  • 2. INTRAVENOUS (systemic)
  • 3. INHALATION (ventilatory)

43
REGIONAL ANESTHESIA
  • SEGMENTAL LOSS OF SENSATION
  • BY BLOCKING NERVE CONDUCTION

44
REGIONAL
  • 1. SPINAL
  • 2. EPIDURAL
  • 4. INTRAVENOUS ( BIER )
  • 5. AXILLARY (INFILTRATION)
  • 6. RETROBULBAR

45
REGIONAL
  • PAIN RELIEF
  • DIAGNOSTIC
  • THERAPEUTIC

46
LOCAL ANESTHETICS
  • AMIDES MAX / DOSE
  • BUPIVACAINE 2 MG/KG
  • LIDOCAINE 7 MG/KG
  • ROPIVACAINE 4 MG/KG
  • MEPIVACAINE 7 MG/KG
  • PRILOCAINE 6MG/KG

47
LOCAL ANESTHETICS
  • ESTERS MAX /DOSE
  • CHLOROPROCAINE 20 MG/KG
  • COCAINE 3 MG/KG
  • NOVOCAINE 12 MG/KG
  • TETRACAINE 3 MG/KG

48
REGIONAL ADDITIVES
  • MUSCLE RELAXANTS
  • NARCOTICS
  • NON-STEROIDAL ANALGESICS

49
GENERAL ANESTHESIA INDUCTION AGENTS
  • INHALATION GASES
  • INTRAVENOUS AGENTS BARBITURATES
  • OPIOIDS
  • BENZODIAZEPINES
  • DIISOPROPYLPHENOL
  • IMIDAZOLE

50
INHALATION AGENTS
  • NITROUS OXIDE
  • HALOTHANE
  • ETHRANE
  • FORANE
  • SUPRANE
  • ULTANE

51
MAC
  • MINIMUM ALVELOAR CONCENTREATION
  • 50 of the population will be
    anesthetized...and wont move upon skin
    incision...or wont jump with a clamp on their
    tail!!!!!!!!!!!

52
MAC
  • MAC- INDUCTION
  • MAC - INTUBATION
  • MAC - INCISION
  • MAC- MAINTENANCE
  • MAC - AMNESIA
  • MAC-BAR
  • MAC-AWAKE

53
UPTAKE AND DISTRIBUTIONBloodGas Coefficient
SolubilityHigher Concentration to Lower
54
INTRAVENOUS AGENTS
  • DISSOCIATIVE DRUGS
  • BARBITUATES
  • DIISOPROPYLPHENOL
  • IMIDAZOLE
  • TRANQUILZERS
  • NARCOTICS
  • NEUROLEPTICS (4 5 COMBINED)

55
DISSOCIATIVE
  • KETAMINE ARYLCYCLOHEXYLAMINE
  • LSD
  • PHENCYCLIDINE

56
BARBITURATES
  • THIOPENTHAL - PENTOTHAL
  • METHOHEXITAL - BREVITAL

57
DIISOPROPYLPHENOL
  • PROPOFOL

58
IMIDAZOLE
  • ETOMIDATE

59
BENZODIAZEPINES(TRANQUILIZERS)
  • ATIVAN - LORAZEPAM
  • VERSED - MIDAZOPAM
  • VALIUM - DIAZEPAM
  • VISTARIL - HYDROXYZINE

60
Benzodiazepines
  • Sedation
  • Anxiolytic - anti anxiety
  • Anticonvulsant
  • Indirect muscle relaxation
  • GABA
  • Amnesia
  • (No analgesia)

61
Benzodiazepines Adverse Effects
  • CNS
  • Increased sedation, ataxia,confusion, dizziness
  • Paradoxical excitation
  • ?age extremes, agitation, anxiety, hallucinations
  • Respiratory depression

62
Benzodiazepines Adverse Effects
  • Cardiovascular - ?P, ?BP
  • Propylene glycol - rapid IV push
  • Constipation
  • Blurred vision
  • Hiccups

63
Benzodiazepine Reversal
  • Romazicon - 0.2 mg up to 1 mg every 1 min.
  • Withdrawal - seizures

64
OPIOIDS
  • MORPHINE
  • DEMEROL
  • FENTANYL
  • SUFENTA
  • ALFENTANIL
  • REMIFENTANIL
  • NON-STEROIDALS (TORADOL)

65
Opiate Receptor Functions
  • ? (mu) Supraspinal analgesia ??
  • Respiratory depression ??
  • Euphoria ,Physical dependence
  • ??(kappa) Analgesia, Sedation
  • ??(sigma) Dysphoria,Hallucinations
  • ??(delta) Unknown
  • ??(epsilon) Unknown

66
Classification of Opioid Agonists and
Antagonists
  • Agonists Agonist-Antagonists Antagonis
    ts
  • Morphine Talwin Narcan
  • Demerol Stadol
    Naltrexone
  • Sufenta Nubain
  • Alfenta
  • Codeine
  • Fentanyl
  • Remifentanil

67
Opioid Adverse Effects
  • Cardiovascular
  • Respiratory
  • GI
  • GU

68
NEUROLEPTIC
  • COMBINATION OF
    NARCOTIC AND TRANQUILIZER
  • ORIGINALLY..LYTIC COCKTAIL
  • 2nd GENERATION...INNOVAR
  • 3rd.GENERATION....PROPOFOL ..NARCOTIC..VERSED

69
ANTIEMETIC
  • H1 BLOCKERS
  • PHENOTHIAZINES
  • BUTYROPHENONES
  • H2 BLOCKERS
  • 5-HT ANTAGONIST
  • ONDANSETRON-ZOFRAN
  • GRANISETRON KYTRIL DOLISETRON -
    ANZEMET

70
AMNESTICS
  • SCOPALOMINE
  • PROPOFOL
  • VERSED
  • NITROUS OXIDE

71
MUSCLE RELAXANTS
  • DEPOLORIZER (SHORT -ACTING)
  • SUCCINYLCHOLINE
  • NON-DEPOLORIZER (LONG - ACTING)
  • MIVACURIUM CURARINE ROCURONIUM
    RAPALON
  • PANCURONIUM VECURONIUM
  • ATRACURIUM

72
REVERSALS
  • NARCOTIC
  • NARCAN
  • BENZODIAZAMINE
  • ROMAZICON
  • MUSCLE RELAXANTS
  • PYRIDOSTIGMINE
  • PROSTIGMIN EDROPHONIUM
  • PHYSOSTIGMINE

73
T.I.V.A.
  • TOTAL INTRAVENOUS ANESTHESIA
  • INDUCTION AGENT
  • TRANQUILER
  • AMNESTIC
  • ANALGESIC
  • MUSCLE RELAXANT

74
BALANCED
  • JUST ENOUGH OF ALL

75
PHASES OF ANESTHESIA
  • INDUCTION
  • MAINTENANCE
  • EMERGENCE

76
INDUCTION
  • ANS
  • SYMPATHETIC
  • PARASYMPATHETIC
  • CARDIOVASCULAR
  • BLOOD PRESSURE
  • BLOOD VOLUME

77
BLOOD VOLUME
  • ESTIMATING ALLOWABLE BLOOD LOSS (EABL)
  • EABL (HCTs -HCTa ) X EBV
  • HCTs
  • s starting
  • a allowed

78
Estimated Blood Volume
  • PREMATURE 100
  • INFANT 90
  • CHILD 80
  • MEN 70
  • WOMEN 60
  • IDEAL WEIGHTht. in cm-100kg
  • 5 ft.100 5
    per in. F
  • 5 ft.100 7
    per in. M

79
OBESE CALCULATION
  • IDE AL WEIGHT
  • 5FT.100
  • FEMALE 1 in 5
  • MALE 1 in 7.5
  • ?????OBESE WT. ADD TO IDEAL
  • WEIGHT

80
INDUCTION
  • POSITION CHANGES
  • PULSE RATE
  • ARRYTHMIAS
  • RENAL -1 CC/KG/HR
  • TEMPERATURE
  • ACID/BASE BALANCE
  • RESPIRATORY

81
RESPIRATION CALCULATIONS
  • RESPIRATORY
  • Vd Vt POX RMV
  • ETCO2
  • PCO2 desired X RMVhavePCO2 perfect
  • PCO2 got RMVwant

82
FLUID MANAGEMENT
  • FLUID THERAPY
  • a) CRYSTALLOID
  • b) COLLOID
  • FLUID THERAPY
  • a)NPO
  • b) MAINTENANCE
  • c) 3rd. SPACE LOSSES
  • d) EBL 31 or 11

83
EPINEPHRINE DILUTION
  • A)1200,000 5 mcg/ml0.15 ml of 11000 in
  • 30 ccs of solution
  • B)1100,00010 mcg/ml0.30 ml of 11000 in
  • 30 ccs of solution
  • C)1300,000 3 mcg/ml0.1 ml of 11000 in
  • 30 ccs of solution

84
EPINEPHRINE
  • CHILDREN.......10 MCG/KG
  • ADULTS...
  • HALOTHANE 1 MCG/KG
  • ENFLURANE 3 MCG/KG
  • DESFLURANE ? MCG/KG
  • SEVOFLURANE ? MCG/KG

85
MONITORED ANESTHESIA CARE
  • HISTORY/ PHYSICAL REQUIRED
  • USUAL STANDARDS OF CARE
  • COST OF SERVICE
  • ALTERNATIVE CASE PLAN
  • USUALLY THE SICKEST

86
MONITORED ANESTHESIA CARE
  • SEDATION-HYNOSIS
  • ANALGESIA
  • AMNESIA
  • PHYSIOLOGICAL STABILITY
  • REVERSIBLE
  • http//www2.kumc.edu/instruction/sah/NurseAnesthes
    ia/nura833/conscious.htm

87
SIGNS - STAGES
  • ANALGESIA
  • EXCITEMENT
  • SURGICAL
  • MEDULLARY DEPRESSION

88
KEY TERMS
  • SECOND GAS EFFECT
  • DIFFUSION HYPOXIA
  • VENTILATORY RESPONSE TO CO2
  • HYPOXIA PULMONARY VASOCONSTRICTION
  • PROTEIN BINDING
  • IONIZATION
  • PRETREATMENT - PRIMINING

89
PREANESTHETIC VISIT
  • Patient education
  • History physical
  • Surgeons or patient choice
  • Informed consent
  • Care Plan development

90
PREANESTHETIC WORK-UP
  • REVIEW
  • CHART
  • LAB VALUES
  • EKG
  • X-RAYS

91
PREANESTHETIC WORK-UP
  • SYSTEMS REVIEW
  • NEURO-MUSCULAR STATUS
  • AIRWAY
  • CARDIOPULMONARY
  • RENAL
  • ENDOCINE
  • GASTROINTESTINAL
  • ALLERGIES
  • DRUG HISTORY

92
History and Physical
  • AIRWAYspecial needs
  • SUBSTANCE ABUSEwithdrawal
  • DIABETEStight control
  • REFLUX..pretreat
  • CARDIOVASCULARGoldman
  • pretreatment need, blood dyscrasia

93
History and Physical
  • Malignant Hyperthermia
  • Myo-neural problems
  • Renal
  • Liver.Enzymes??..metabolism
  • Gastrointestinalelectrolytes
  • Endocrinethyroid, steroids
  • Herbal intake

94
History and Physical
  • Electrocardiogram
  • Atrial fib-flutter
  • 1-2-3 Block
  • AV disassociation
  • PVCs-PACs
  • ST segmentischemia
  • QT Interval
  • Tall p.deep q
  • W.P.W

95
ANESTHESIA CARE PLAN
96
INFORMED CONSENT
Write a Comment
User Comments (0)
About PowerShow.com